Nicotine Lozenge
Product Images NDC 11822-0873

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nicotine (NDC 11822-0873). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rite Aid Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nicotine Lozenges (8739b983c7 F)

This text appears to be the packaging details for a nicotine product, specifically a 4 mg nicotine polacrilex lozenge. The packaging includes instructions for usage, such as not smoking within 30 minutes of waking up and using the lozenge if you typically smoke your first cigarette within 30 minutes of waking up. It also includes a warning label, dosage information, and the quantity of lozenges in the package.*

FDA Label Image

Nicotine Lozenges (873b983c7 B)

This text is a drug information sheet on how to use the M Nicotine lozenge to quit smoking. It provides details on the active ingredients, warnings, and directions on how to use the lozenge for the best results and minimize side effects. It also includes a schedule for using the lozenge for up to 12 weeks. Inactive ingredients and contact information for RiteAid are also provided.*

FDA Label Image

Wallet Card (Image 01)

FDA Label Image

Wallet Card (Image 02)

The text describes a wallet card that provides information about American Lung Association, American Cancer Society, American Heart Association and a Quitting Buddy or Friend who has Quit. These are contact numbers that can be used to seek help.*

FDA Label Image

Smoke Free Logo (Image 03)

FDA Label Image

Upc Example (Image 04)

FDA Label Image

Stickers (Image 05)

This text appears to be a set of instructions for someone attempting to quit smoking, detailing a schedule for taking lozenges of varying frequency over several weeks. It suggests taking 1 lozenge every 1 to 2 hours on the quit date (beginning of week #1), then gradually reducing the frequency until taking 1 lozenge every 4 to 8 hours at the beginning of week #7. Finally, it recommends taking 1 lozenge every 4 to 8 hours beginning on week #10, which is 12 weeks after the quit date. These instructions are intended to be added to a calendar as reminders.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.